Valuation: Stem Cells Spin S.A.

Market Cap	20.67M 5.45M 4.76M 4.4M 4.05M 7.64M 525M 7.81M 52.55M 257M 20.47M 20.02M 885M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	20.75M 5.47M 4.78M 4.41M 4.07M 7.67M 527M 7.84M 52.76M 258M 20.56M 20.11M 889M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-15	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-13	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
13/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
14/08/23	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	31/12/2016

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	27/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	14/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	+21.95%	+33.69%	+89.39%	+38.89%	5.45M
LONZA GROUP AG	-1.29%	-3.11%	-0.35%	+3.09%	49.18B
REVOLUTION MEDICINES, INC.	+3.90%	-0.39%	+386.06%	+593.85%	39.58B
BEONE MEDICINES AG	-1.70%	+4.46%	+5.93%	+60.25%	34.69B
IQVIA HOLDINGS INC.	-2.01%	-0.76%	+28.41%	-8.01%	34.42B
CELLTRION, INC.	+0.06%	+0.34%	+2.38%	+34.38%	27.11B
ASCENDIS PHARMA A/S	+0.46%	-3.49%	-	-	16.21B
MEDPACE HOLDINGS, INC.	-0.04%	-0.09%	+72.42%	+115.55%	15.36B
EUROFINS SCIENTIFIC SE	+1.12%	+1.91%	+14.54%	+19.16%	14.05B
ICON PUBLIC LIMITED COMPANY	0.00%	+1.36%	+18.43%	-30.79%	13.02B
Average	+2.24%	+2.46%	+68.58%	+91.82%	24.36B
Weighted average by Cap.	-0.05%	-0.18%	+79.44%	+123.31%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-14 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
17/07/26	PLN 0.5000	+21.95%	10,954
14/07/26	PLN 0.4100	+9.63%	26

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 17/07/2026			5-day change	1st Jan Change
0.5000 ^PLN	+21.95%		+33.69%	+23.15%

1 day	+21.95%
1 week	+33.69%
Current month	+25.00%
1 month	+19.62%
3 months	+25.00%
6 months	+26.90%
Current year	+23.15%

1 week	0.41	0.5
1 month	0.37	0.5
Current year	0.33	0.5
1 year	0.26	0.52
3 years	0.14	0.82
5 years	0.14	1.23
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.32K 12.51K 11.55K 10.64K 20.06K 1.38M 20.5K 138K 675K 53.77K 52.59K 2.32M	65.74K 17.34K 15.15K 13.98K 12.89K 24.29K 1.67M 24.83K 167K 818K 65.12K 63.69K 2.82M
Net income	-520K -137K -120K -111K -102K -192K -13.22M -197K -1.32M -6.47M -515K -504K -22.28M	-526K -139K -121K -112K -103K -194K -13.35M -199K -1.34M -6.54M -521K -509K -22.51M
Net Debt	69.28K 18.28K 15.97K 14.74K 13.58K 25.6K 1.76M 26.17K 176K 862K 68.63K 67.13K 2.97M	84.58K 22.31K 19.5K 17.99K 16.58K 31.26K 2.15M 31.95K 215K 1.05M 83.79K 81.95K 3.62M

Stem Cells Spin S.A. Share Price

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates